Listing at ▲ + ₹172.10 Per Share

KRM Ayurveda SME IPO 2026 – GMP, Financials, Risks & Review

Latest Grey Market Premium & IPO Details

KRM Ayurveda IPO 2026 – Key Info & Highlights

KRM Ayurveda SME IPO opens on 21 Jan 2026 at an attractive price band of ₹128–₹135 per share. Track today’s KRM Ayurveda Ltd IPO GMP, lot size, reservation quota, financial performance, DRHP highlights, and real-time subscription status in one place. Also understand which GMP is considered good for an IPO before investing.

📌 IPO Details

Company Name KRM Ayurveda IPO
Sector / Industry Ayurveda / Wellness Services
IPO Open Date 21-01-2026
IPO Close Date 23-01-2026
Allotment Date 27-01-2026
Refund Date 28-01-2026
Share Credit Date 28-01-2026
Listing Date 29-01-2026
Price Band ₹128 - ₹135
Lot Size 1000 Shares
Min Investment ₹2,70,000 ( 2 lot price )
Net Issue Size ₹77.49 Cr
Fresh Issue ₹71.77 Cr
IPO Listing At NSE SME
DRHP View DRHP
Issue Type Book Build Issue
Face Value ₹10 Per Equity Share
Promoter Holding Pre IPO 92.15 %

* All Dates are provisional

Quota Allocation

Category Allocation (%)
Retail Investors 35%
QIB (Qualified Institutional Buyers) 500%
HNI (High Net Worth Individuals) 15%

📈 Grey Market Premium (GMP) Day-wise Trend

GMP Date GMP Price Trend Estimated Listing Price Estimated Profit* Last Updated
29-01-2026 ₹22.50 - ₹157.50 ₹22500.00 29-01-2026 08:58
28-01-2026 ₹22.50 ▲ ₹157.50 ₹22500.00 28-01-2026 23:26
27-01-2026 ₹21.00 ▲ ₹156.00 ₹21000.00 27-01-2026 22:29
Note: Grey Market Premium is unofficial and indicative only.

📝 About KRM Ayurveda

Established on 3 September 2019, KRM Ayurveda Limited is an Ayurvedic healthcare and wellness company that operates a growing network of hospitals and clinics across various cities in India. The company integrates traditional Ayurvedic principles with structured and systematic healthcare services to serve patients on a broad scale.

Currently, KRM Ayurveda operates 6 hospitals and 5 clinics at different locations in the country, offering both in-patient and out-patient Ayurvedic treatment services. Along with its domestic operations, the company has also expanded its presence internationally through telemedicine consultations and overseas sales, enabling access to Ayurvedic treatments beyond India.

The company is actively engaged in the manufacturing and distribution of Ayurvedic products, including herbal and botanical medicines, formulations, dietary supplements, and wellness-related products. These offerings are developed to support treatment effectiveness and promote preventive healthcare.

KRM Ayurveda conducts its healthcare services and product manufacturing activities in compliance with applicable regulatory guidelines and holds the necessary registrations and certifications, including Certificate No. AH-2023-0186.

In view of the growing demand for alternative and preventive healthcare services, KRM Ayurveda focuses on expanding its hospital and clinic network, strengthening its telemedicine capabilities, and enhancing its product portfolio. The company aims to improve accessibility to Ayurvedic healthcare services through physical infrastructure, digital platforms, and standardized treatment processes.

KRM Ayurveda Revised Financials

Profit / Loss & Total Assets (Last 3 Financial Years)

Financial Year Revenue (₹ Cr) Profit / Loss (₹ Cr) Total Assets (₹ Cr)
FY 2023 89.29 +7.60 62.84
FY 2024 67.16 +3.41 69.92
FY 2025 76.55 +12.10 83.60

Note: Financial data is sourced from the company’s DRHP. Figures are in ₹ Crore.

KRM Ayurveda SME IPO Objects of Issue
  • Expansion of Tele-medicine Operations – To strengthen and scale the company’s Ayurvedic tele-consultation services by developing operational infrastructure and service delivery systems.
  • Capital Expenditure for Hospitals and Clinics – To upgrade existing Ayurvedic hospitals and clinics and invest in infrastructure for new healthcare facilities.
  • Procurement of IT Systems and Software – To purchase hospital management software, CRM systems, hardware, and other digital tools to improve operational efficiency.
  • Hiring of Human Resources – To recruit qualified doctors, therapists, medical staff, and support personnel for business expansion.
  • Repayment / Prepayment of Borrowings – To repay or prepay certain existing borrowings in order to reduce interest costs and strengthen the balance sheet.
  • General Corporate Purposes – To meet general business requirements and support the company’s ongoing operations and strategic initiatives.
KRM Ayurveda SME IPO – Key Strengths
  • Integrated Ayurvedic Healthcare Business Model – KRM Ayurveda operates a network of Ayurvedic hospitals, clinics, and wellness centres, providing in-patient and out-patient treatments through an integrated healthcare delivery model, which supports long-term scalability and patient retention.
  • Experienced Promoters and Professional Management Team – The company is led by promoters and senior management with hands-on experience in Ayurvedic healthcare services, hospital operations, and wellness centre management, which strengthens execution and operational control.
  • Pan-India Presence with Multi-City Operations – KRM Ayurveda has established its operational footprint across multiple cities in India, enabling wider market reach, brand visibility, and access to a growing AYUSH healthcare market.
  • Diversified Ayurvedic Treatment and Wellness Services – The company offers a wide range of services including Panchakarma therapy, lifestyle and chronic disorder treatments, preventive healthcare programs, and Ayurvedic tele-medicine consultations, reducing dependency on a single revenue stream.
  • Improving Financial Performance as per DRHP – According to the DRHP, KRM Ayurveda SME IPO financials indicate recovery in revenue and a notable improvement in profitability in the latest financial year, reflecting better operational efficiency and cost management.
KRM Ayurveda SME IPO – Risk Factors
  • Dependence on Ayurvedic Services – The business relies mainly on Ayurvedic healthcare. Any decline in demand or regulatory changes may impact operations and revenue.
  • Geographic Concentration – Operations are limited to selected regions. Adverse regional developments could affect business performance.
  • Skilled Staff Dependency – The company depends on qualified Ayurvedic doctors and staff. Talent shortages or high attrition may affect service quality.
  • SME Listing Risk – Shares will be listed on the NSE SME platform, which may have lower liquidity compared to the main board.
  • Financial Variability – Past financial performance has shown fluctuations, and future results may also vary.
  • Regulatory Compliance – The company is subject to AYUSH and healthcare regulations. Non-compliance could impact business and reputation.

KRM Ayurveda Limited

Integrated Ayurvedic Healthcare & Wellness Services Provider

Founded in: 2019
MD / CEO: Mr. Puneet Dhawan
Address: A-16, G.T. Karnal Road,
North West Delhi,
New Delhi – 110033, India
Website: www.krmayurvedaindia.com
Phone: +91 9289101700
Email: compliance@krmayurveda.com
Services: Ayurvedic Hospitals & Clinics, Panchakarma Therapy, Wellness Programs, Preventive Healthcare, Tele-medicine (Ayurveda), Diet & Lifestyle Consultation
Disclaimer: IPO related data is compiled from publicly available sources like NSE, BSE, and company filings. Grey Market Premium (GMP) is unofficial and subject to change. This information is for educational purposes only and not investment advice.

IPO Quick Info

Open Date
21 Jan 2026
Close Date
23 Jan 2026
IPO Status
Upcoming
Time Left
← Back to IPO List
Lead Manager(s)
  • Nexgen Capital Markets Ltd.
By: IPO Info India Team
Last Updated: 31 Jan 2026, 12:27 AM

Frequently Asked Questions

KRM Ayurveda Limited is an integrated Ayurvedic healthcare and wellness company operating a network of Ayurvedic hospitals and clinics in India. The company offers Panchakarma therapies, chronic and lifestyle disorder treatments, preventive healthcare programs, and Ayurvedic tele-medicine consultations, along with the manufacturing of Ayurvedic medicines, herbal formulations, and wellness products.